Judge denies Trump bid to cut Jan. 6 riot language from D.C. election indictment
Donald Trump is due to stand trial in March on federal criminal charges related to his attempt to undo the election victory of President Joe Biden.
Wall Street turns to Nvidia earnings in the week ahead as stocks try to keep their November momentum
The chip giant, which reports Tuesday, is anticipated to show solid third-quarter results.
Amazon cuts ‘several hundred’ jobs in Alexa division
The company’s devices and services unit, which includes Alexa, was hit by an earlier round of layoffs.
Fed’s Susan Collins says more rate hikes can’t be taken off the table yet
Other officials have been saying much of the same, essentially that inflation is showing progress but still has a way to go.
If you want to be the ultimate contrarian next year, bet on these things happening
Bank of America strategist Michael Hartnett gives his contrarian trades to profit from unexpected outcomes in 2024.
Ray Dalio says U.S. reaching an inflection point where the debt problem quickly gets even worse
Soaring U.S. government debt is reaching a point where it will begin creating larger problems, the hedge fund titan said Friday.
More part-time workers to get access to employer retirement plans next year
Changes in the federal law, coupled with a strong labor market and state mandates are opening up employer-sponsored retirement plans to part-time workers.
UAW members ratify new contract with Chrysler owner Stellantis
A majority of the Stellantis’ plants approved the deal, which, like those at GM and Ford, includes at least 25% wage increases.
Ex-Meta staffers see booming business targeting online disinformation after two wars break out
With online disinformation and violent content spreading more rapidly since the Israel-Hamas war broke out, new startups are seeing a boom in demand.
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
The CDC’s move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
